Dicerna Pharma (DRNA) Misses Q2 EPS by 55c

Dicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($1.15), $0.55 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Reading (RDI) Tops Q2 EPS by 4c